600-Patient study seeks answers for mysterious adrenal gland disorders
NCT ID NCT07191951
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is building a large group of 600 adults with various adrenal diseases, like Cushing's syndrome and adrenal tumors. Researchers will track their standard treatments (surgery, radiation, or medication) and outcomes. The goal is to learn more about these conditions, improve how they are diagnosed, and find better ways to personalize care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could lead to better diagnostic tools and more personalized treatment plans for people with adrenal diseases.
- What could go wrong
- This is an observational study, not a treatment trial. It aims to gather information, not test a new cure. Results may take years and may not directly change care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADRENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jiang yiran
RECRUITINGShanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can a radioactive 'Smart Bomb' take down resistant childhood cancers?
- Can a radioated molecule shrink untreatable neuroblastoma?
- Could a simple saliva test replace blood draws for hormone monitoring?
- Liver tumors targeted directly: old pump, new drug
- New drug aims to shrink rare adrenal tumors